AMEDISYS INC. 2023-2024 Proxy Voting Records

Description as filed by funds: To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of June 26, 2023, by and among UnitedHealth Group Incorporated ("Parent"), Amedisys, Inc. ("Amedisys") and Aurora Holdings Merger Sub Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will merge with and into Amedisys, with Amedisys continuing as the surviving corporation and as a wholly owned subsidiary of Parent (the "Merger").

AMEDISYS INC.’s own tally for this item (“1. The adoption of the Merger Agreement”): 25,069,466 for, 30,082 against — passed, per its Form 8-K filed September 8, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Each of the two proposals voted on was approved by the requisite vote of the Company's stockholders.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 85 asset managers below reported 10,104,163 for, 45,400 abstained.

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

Description as filed by funds: To adopt the Agreement and Plan of Merger (as it may be amended from time to time "Merger Agreement ), date as of June 26, 2023, by and among UnitedHealth Group Incorporated (" Parent") , ("Amedisys") and Aurora Holdings Meger Sub Inc., a wholly owned subsidiary of Parent (" Meger Sub ") ,pursuant to which Meger Sub will meger with and into Amedisys continuing as the surviving corporation and as wholly owned subsidiary of Parent ( the "Merger")

AMEDISYS INC.’s own tally for this item (“1. The adoption of the Merger Agreement”): 25,069,466 for, 30,082 against — passed, per its Form 8-K filed September 8, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Each of the two proposals voted on was approved by the requisite vote of the Company's stockholders.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 19 asset managers below reported 399,361 for.

Description as filed by funds: APPROVE MERGER AGREEMENT

AMEDISYS INC.’s own tally for this item (“1. The adoption of the Merger Agreement”): 25,069,466 for, 30,082 against — passed, per its Form 8-K filed September 8, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Each of the two proposals voted on was approved by the requisite vote of the Company's stockholders.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 2 asset managers below reported 18,545 for.

Description as filed by funds: To approve the adjournment of the Amedisys Special Meeting, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Amedisys Special Meeting to approve proposal 1 to adopt the Merger Agreement.

The 104 asset managers below reported 9,617,983 for, 880,248 against, 50,693 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 104 asset managers. See all 104 in the interactive database.

The 2 asset managers below reported 18,545 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Amedisys named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement.

AMEDISYS INC.’s own tally for this item (“2. On a non-binding, advisory basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger”): 23,746,599 for, 1,340,582 against — passed, per its Form 8-K filed September 8, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on a non-binding, advisory basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 102 managers: 10,285,638 for, 243,889 against, 19,163 abstained. Showing the 25 largest; see all in the interactive database.

No total is shown for the institutional-manager reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; see all in the interactive database.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 2 managers: 18,545 for.

Institutional-manager reports, all 6 managers: 121,731 for.